Skip to main content
. 2022 Apr 18;13(4):360. doi: 10.1038/s41419-022-04845-2

Fig. 1. MEOX2 shows overabundance in glioma and is associated with a poor prognosis.

Fig. 1

A Circos plot displayed the genes with a high frequency of CNV change on human chromosomes. The red arrow denotes MEOX2. B Different types of MEOX2 genetic alterations in glioma samples from TCGA database (n = 656). C The correlation of MEOX2 expression with its CNV. D The mRNA levels of MEOX2 in gliomas with different WHO grades from TCGA and CGGA databases. E Overall survival (OS) curves of patients with glioma from TCGA and CGGA databases stratified by MEOX2 expression. F The protein expression of MEOX2 in gliomas with different histological grades was detected by immunoblot. G The protein expression of MEOX2 in different glioma cell lines or glioma stem cells and NHA were evaluated by immunoblot. H Representative IHC images of MEOX2 protein in gliomas with different histological grades and NBT. Bar = 20 µm. I The semi‑quantitative for the IHC results of MEOX2. **p < 0.01, ****p < 0.0001.